Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Part 1 of an ongoing 12-part COVID-19 series, Vikramjit Mukherjee, MD, provides a brief update on the latest incidence trends, the role of serology in disease assessment, and newly published data from the ACTT-1 trial comparing remdesivir vs placebo for severe COVID-19 treatment. After the update, Dr. Mukherjee answers critical clinician questions on COVID-19 transmission, diagnosis, and management.
Content based on an online CME program supported by an independent educational grant from Gilead Sciences.
Link to full program: https://www.clinicaloptions.com/infectious-disease/programs/covid19-resources
Jens D. Lundgren, MD, DMSc provides a brief update on COVID-19 and answers clinician questions in the Clinical Care Options (CCO) Infectious Disease podcast
Watch this presentation by Professor David Heymann discussing the concept of herd immunity and considerations for estimating the herd immunity threshold for SARS-CoV-2
Download free slides reviewing the latest updates on COVID-19 epidemiology and emerging data on diagnosis, symptoms, management, and treatment
Presentation by Professor Jens D. Lundgren discussing the current evidence and recommendations regarding the use of convalescent plasma to treat COVID-19 from CCO
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.